← Leaderboards
Lindon H Young
Philadelphia College Of Osteopathic Med
$2,098,961
Attributed
$2,843,410
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,843,410 · 4
By mechanism
R44$1,488,899 · 1
R43$911,261 · 2
R15$443,250 · 1
Top collaborators
- Thomas Argentieri1 shared
Others in their field
Top investigators on “Animals”
- David Heimbrook · Leidos Biomedical Research, Inc.$534,904,829
- Richard Webby · St. Jude Children'S Research Hospital$259,408,394
- Eric S Lander · Whitehead Institute For Biomedical Res$209,574,154
- Dennis R. Burton · Scripps Research Institute$204,129,233
- Richard K. Wilson · Washington University$130,501,539
- Mark S Klempner · Tufts Medical Center$129,182,794
Research focus
AnimalsPeptidesReperfusion TherapyIschemiaSuperoxidesProtein Kinase C EpsilonReperfusion InjuryInjuryInhibitor/AntagonistTissuesClinical TrialsCardioprotectionCell MembraneIn VivoIndexingMyocardial IschemiaMorbidity - Disease RateNitric OxideInfarctionHeart FunctionMonitorOrganRestorationAcute
Grant awards (6)
Minimizing myocardial damage and loss of cardiac function post myocardial infarction using Targeted PKC inhibitors 002 and 004.$1,488,899
R44 · FY2025 · HL · contact PI
Young, Lindon H$560,261
R43 · FY2021 · HL · contact PI
The effects of protein kinase C epsilon peptide inhibitor (YT-001) in warm murine kidney ischemia-reperfusion$51,000
R43 · FY2020 · DK · contact PI
The effects of protein kinase C epsilon peptide inhibitor (YT-001) in warm murine kidney ischemia-reperfusion$300,000
R43 · FY2019 · DK · contact PI
In vivo and ex vivo mechanisms related to eNOS uncoupling during reperfusion$225,000
R15 · FY2008 · HL · contact PI
PKC isoform inhibition in cardiac ischemia/reperfusion$218,250
R15 · FY2004 · HL